Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD) is a group of chronic inflammatory conditions primarily affecting the colon and small intestine, with Crohn's disease and ulcerative colitis being the main types. Symptoms include diarrhea, unexplained weight loss, abdominal pain, bloating, and fatigue, and while the exact cause is unknown, it is believed to involve autoimmune interactions between the immune system, genes, gut microbiome, and lifestyle factors; although there is no cure, IBD can be managed with medication, lifestyle changes, and, in some cases, surgery.
Health Outcomes
- Absence of Microbial Translocation
- Accelerated Colitis Recovery
- Accurate Enumeration of Viable Probiotic Bacteria
- Achieved Histological Remission
- Activated Immune Response
- Activated Intestinal Immune Response
- Activated Systemic Immunoreactivity in Peyer's Patches
- Activation of Nrf2 Pathway
- Activation of Peyer's Patches Plasmacytoid Dendritic Cells
- Adjusted Intestinal Microbiota Abundance
- Alleviated Diarrhea
- Alleviated Histopathological Changes in the Colon
- Alleviated Intestinal Damage
- Alleviated Intestinal Disease
- Alleviated Intestinal Metabolic Disorders
- Alleviated Rectal Bleeding
- Alleviated Symptoms of Mild to Moderate Crohn's Disease
- Altered Bacterial Proportions
- Altered Bifidobacterial Population
- Altered Bifidobacterium Profile
- Altered CD4+ T-cell Cytokine Levels
- Altered Chemokine Response
- Altered Colonic Microbial Communities
- Altered Cytokine Levels in Jejunal Mucosa
- Altered Dominant Intestinal Bacterial Composition
- Altered Endocannabinoid System Function Due to Specific Strain
- Altered Enteric Bacterial Flora
- Altered Expression of Immune Products
- Altered Expression of Immune-Related Genes
- Altered Faecal Microbiota Profile
- Altered Fecal Butyrate Levels
- Altered Fecal Metabolite Levels
- Altered Gastrointestinal Microbial Communities
- Altered Gastrointestinal Microbiome Composition
- Altered Gut Metabolome
- Altered Gut Microbial Community
- Altered Gut Microbial Transcriptomic Response
- Altered IgA Concentration in Ileal Flushes
- Altered Intestinal Mucosa Morphology
- Altered Intestinal Transit
- Altered Lactobacilli Composition
- Altered Microbial Composition
- Altered Microbial Phyla Abundance
- Altered Microbial Population Composition
- Altered Microbial Profile
- Altered Pro-Inflammatory Cytokine Levels
- Altered Relative Abundance of Specific Bacteria
- Altered Serum IL-6 Levels
- Altered Serum Immune Protein Levels
- Altered Short-Chain Fatty Acid Production
- Altered Short-Chain Fatty Acid Production by Gut Microbiota
- Altered Spirochaetes Abundance in Pig Microbiota
- Altered Stool Microbiota Profile
- Altered T Cell Migratory Behavior
- Attenuated Enterocyte Injury
- Attenuated Gut Dysbiosis
- Balanced Gut Microbiome
- Balanced Gut Microbiota
- Balanced T-Cell Differentiation
- Balanced Treg/Th17 Regulation
- Baseline Intestinal Permeability
- Binding to Goblet Cell Mucus
- Changes in Health Status from Probiotic Intervention
- Chronic Immune Activation
- Colonization of Fibrolytic Bacteria
- Colonization of the Intestine
- Confirmed Safety of Oral Probiotic Administration
- Corrected Gut Microbiota Disorders
- Counterbalanced Gut Dysbiosis
- Decreased Digestive Enzyme Activities in Ileum
- Decreased Hafnia-Obesumbacterium Genus
- Decreased IFN-γ Levels
- Decreased Mannitol Flux
- Decreased Prevotella Copri Relative Abundance
- Decreased Roseburia faecis Relative Abundance
- Decreased TNF-α Production in Immune Cells
- Degraded Non-Digestible Carbohydrates
- Delayed Onset of Colitis
- Developed Anemia
- Disrupted Gut Microbiota Distribution
- Disrupted Mucosal Barrier
- Diversified B-Cell Populations in the Colon
- Diversified B-cell Populations in the Lamina Propria
- Effective Treatment of Crohn's Disease
- Elevated Blood Cytokine Levels
- Elevated ERK Levels in Intestinal Stem Cells
- Elevated Fecal Acidic Steroid Levels
- Elevated Fecal Lactate Levels
- Elevated IL-22 Levels
- Elevated IL-6 Levels
- Elevated Ileum IL-4 Levels
- Elevated Interleukin-17 Levels
- Elevated Interleukin-6 Levels
- Elevated Serum Metabolites in Response to Inflammation
- Elevated Serum TNF-α Levels
- Elevated TNF-α Expression Level
- Elevated β-Catenin Levels in Intestinal Stem Cells
- Enhanced Abundance of Beneficial Bacterial Species
- Enhanced Adherence to Intestinal Epithelial Cells
- Enhanced Adhesion to Colon Cells
- Enhanced Adhesion to Enterocyte-like Cells
- Enhanced Adjuvanticity
- Enhanced Anti-Inflammatory Cytokine Production
- Enhanced Anti-Inflammatory Cytokine Secretion
- Enhanced Anti-inflammatory Cytokine Expression During Healing
- Enhanced Anti-inflammatory Cytokine Levels
- Enhanced Anti-inflammatory Properties
- Enhanced Anti-inflammatory Response
- Enhanced Antigen Uptake
- Enhanced Antioxidant Levels
- Enhanced Beneficial Bacteria in Intestinal Microbiota
- Enhanced Beneficial Metabolite Production
- Enhanced Beneficial Microbial Populations
- Enhanced Colon Bacterial Diversity
- Enhanced Colonic Mucosa Adhesion
- Enhanced Colorectal Homeostasis
- Enhanced Cytokine Production
- Enhanced Cytokine Response
- Enhanced Dendritic Cell Recruitment in Intestinal Villi
- Enhanced Differentiation of Intestinal Stem Cells into Goblet Cells
- Enhanced Digestive Process Survival
- Enhanced Diversity of Protective Bifidobacterial Populations
- Enhanced Flavonoid Metabolism
- Enhanced Functional Gene Presence in Small Intestine
- Enhanced GLP-2 Secretion
- Enhanced Gas Passing
- Enhanced Goblet Cell Function
- Enhanced Goblet Cell Regeneration
- Enhanced Growth and Development
- Enhanced Gut Flora Composition
- Enhanced Gut Health
- Enhanced Gut Microbiome Health
- Enhanced Gut Microbiota
- Enhanced Gut Microbiota Diversity
- Enhanced Gut Microbiota Maturation
- Enhanced Gut Microbiota Stability
- Enhanced Gut Probiotic Bacteria Propagation
- Enhanced Gut Probiotic Levels
- Enhanced Host-Microbe Balance
- Enhanced IL-12 Production
- Enhanced Immune Response Regulation
- Enhanced Immune Signaling Molecule Production
- Enhanced Immunogenicity
- Enhanced Immunomodulatory Function
- Enhanced Immunoregulatory Function
- Enhanced Inflammatory Response
- Enhanced Interleukin-10 Production
- Enhanced Intestinal Barrier Function
- Enhanced Intestinal Cell Adhesion
- Enhanced Intestinal Defense Maturation
- Enhanced Intestinal Development
- Enhanced Intestinal Epithelial Cell Adhesion
- Enhanced Intestinal Epithelial Maturation
- Enhanced Intestinal Immunity
- Enhanced Intestinal Innate Mucosal Immunity
- Enhanced Intestinal Integrity
- Enhanced Intestinal Lactobacillus Community
- Enhanced Intestinal MUC2 Secretion
- Enhanced Intestinal Microbiota Maturation
- Enhanced Intestinal Morphometry
- Enhanced Intestinal Mucin Production
- Enhanced Intestinal Mucosal Cell Protection
- Enhanced Intestinal Repair Processes
- Enhanced Jejunal Immune Response
- Enhanced Leukocyte Recruitment
- Enhanced Lymphocyte Proliferation
- Enhanced Membrane Barrier Integrity
- Enhanced Metabolism in Small Intestine Microbiota
- Enhanced Microbiota Recovery
- Enhanced Mitochondrial Fitness of Intestinal Regulatory T-cells
- Enhanced Mucosal Immune Function
- Enhanced Mucosal Immune Response
- Enhanced Nutrient Bioavailability
- Enhanced Phagocytic Capacity of Mononuclear Phagocytes
- Enhanced Prebiotic Activity
- Enhanced Pro-Inflammatory Cytokine Response
- Enhanced Probiotic Bacteria Count
- Enhanced Probiotic Growth
- Enhanced Probiotic Gut Adhesion
- Enhanced Regulatory Immune System Development
- Enhanced Regulatory T Cell Development
- Enhanced SCFA Production
- Enhanced Serum Metabolite Levels Against Inflammation
- Enhanced Suppressive Function of Intestinal Tregs
- Enhanced T- and B-Lymphocyte Proliferation
- Enhanced Tight Junction Integrity
- Exercise-Induced Gastrointestinal Symptoms
- Formation of Bifidobacteria Predominant Microbiota
- Gastrointestinal Survival
- Gastrointestinal Tract Persistence
- Germination of Probiotics in Small Intestine
- Good Tolerance to Lactobacillus Reuteri
- Gut Colonization by Saccharomyces boulardii
- Gut Localization of Lactobacillus brevis
- Healed Colitis
- Healthy Gut Microbiome
- High Viability of Probiotic Lactobacillus crispatus BC4 in Cheese
- Immune Response to Rotavirus Vaccine Antigen
- Impaired Intestinal Barrier Function
- Improved Abdominal Pain Severity
- Improved Abdominal Pain in Colitis Patients
- Improved Abundance of Beneficial Bacteria
- Improved Adherence to Enterocytes
- Improved Alpha Diversity of Intestinal Microbiota
- Improved Antigen-Specific IgA Secretion
- Improved Antioxidant Defense
- Improved Antioxidant and Anti-Inflammatory Response
- Improved Apparent Digestibility of Fiber
- Improved Beneficial Intestinal Bacteria
- Improved Beneficial Intestinal Microbiota
- Improved Bifidobacteria Levels
- Improved Bifidobacterium-Dominated Microbiota
- Improved Bifidogenic Response
- Improved Bioavailability
- Improved Bowel Function
- Improved Bowel Habits
- Improved Bowel Movement Frequency
- Improved Bowel Movements
- Improved Bristol Stool Type
- Improved CD4- CD8+ low T Cell Percentage in Ileum
- Improved Cellular Immune Response
- Improved Chronic Constipation
- Improved Colitis
- Improved Colitis Survival
- Improved Colitis Symptoms
- Improved Colon Cancer Symptoms
- Improved Colon Pain
- Improved Colonic Antioxidant Levels
- Improved Colonic Delivery
- Improved Colonic Delivery Feasibility of Oxygen-Sensitive Probiotics
- Improved Colonic Health
- Improved Colonic Histology
- Improved Colonic Histopathology
- Improved Colonic Immune Response
- Improved Colonic Microbial Diversity
- Improved Colonic Microenvironment
- Improved Colonic Mucosal Integrity
- Improved Colonization of Gastrointestinal Tract by Lactobacilli
- Improved Community Diversity of Intestinal Microbiota
- Improved Constipation Symptoms
- Improved Crohn's Disease Symptoms
- Improved Crypt Hyperplasia
- Improved Cytokine Levels
- Improved Cytokine Production
- Improved Degradability of Acid Detergent Fiber
- Improved Diarrhea Symptoms
- Improved Digestibility
- Improved Digestibility of Amino Acids
- Improved Digestibility of Neutral Detergent Fiber
- Improved Digestive Function
- Improved Digestive Health
- Improved Digestive Performance
- Improved Digestive Symptoms
- Improved Digestive Viability
- Improved Diversity of Gut Microbiota
- Improved Endotoxemia-related Inflammation
- Improved Enteral Nutrition Achievement Time
- Improved Enteral Nutrition Tolerance
- Improved Enteral Nutrition Uptake
- Improved Epithelial Barrier Function
- Improved Epithelial Barrier Integrity
- Improved Epithelial Permeability
- Improved Faecal Dry Matter
- Improved Fecal Acetate Recovery
- Improved Fecal Microbial Profile
- Improved Fecal Microbiota
- Improved Fecal Microbiota Diversity
- Improved Fecal Short-Chain Fatty Acid Levels
- Improved Fecal Water Content
- Improved Feed Utilization
- Improved Flatus
- Improved Formula Tolerance
- Improved Functional Genes in Intestinal Microbiota
- Improved Functional Properties of Food
- Improved Gastrointestinal Function
- Improved Gastrointestinal Health
- Improved Gastrointestinal Inflammation
- Improved Gastrointestinal Microbiome Balance
- Improved Gastrointestinal Resistance
- Improved Gastrointestinal Score
- Improved Gastrointestinal Symptom Rating Scale Score
- Improved Gastrointestinal Symptom Score
- Improved Gastrointestinal Symptoms
- Improved Gastrointestinal Tolerance
- Improved Gastrointestinal Viability
- Improved Gastrointestinal Well-Being
- Improved General GI Health Status
- Improved Gross Morphology of Intestinal Tissue
- Improved Growth of Beneficial Bacteria
- Improved Gut Adhesion
- Improved Gut Bacterial Diversity
- Improved Gut Barrier Function
- Improved Gut Barrier Morphology
- Improved Gut Dysbiosis
- Improved Gut Flora Diversity
- Improved Gut Flora Modulation
- Improved Gut Health
- Improved Gut Health (Lower Faecal pH)
- Improved Gut Homeostasis
- Improved Gut Immunity
- Improved Gut Inflammation
- Improved Gut Integrity
- Improved Gut Microbial Alpha Diversity
- Improved Gut Microbial Persistence
- Improved Gut Microbial Population
- Improved Gut Microbiome
- Improved Gut Microbiome Composition
- Improved Gut Microbiome Diversity
- Improved Gut Microbiome Function
- Improved Gut Microbiome Health
- Improved Gut Microbiome Recovery
- Improved Gut Microbiota
- Improved Gut Microbiota Balance
- Improved Gut Microbiota Composition
- Improved Gut Microbiota Composition in Small Intestine
- Improved Gut Microbiota Distribution
- Improved Gut Microbiota Diversity
- Improved Gut Microbiota Fermentation
- Improved Gut Microbiota Growth Medium Suitability
- Improved Gut Microbiota Homeostasis
- Improved Gut Microbiota Richness
- Improved Gut Microbiota Structure
- Improved Gut Microbiota-Related Disease Support in Ulcerative Colitis
- Improved Gut Microbiota-Related Pathways
- Improved Gut Microflora
- Improved Gut Morphology
- Improved Gut Mucosa Health
- Improved Gut Mucosal Histology
- Improved Gut Permeability
- Improved Gut Protection
- Improved Gut Resilience
- Improved Gut Stress Resistance
- Improved Gut Tolerance
- Improved IBD Remission Maintenance
- Improved IL-10/TNF-α Ratio
- Improved IgA Production
- Improved IgG Response to Vaccination
- Improved Ileal Histomorphometry
- Improved Immune Cell Chemotactic Activity
- Improved Immune Regulation
- Improved Immune Response in Individuals with Poor Pretreatment
- Improved Immune System Dialog via EPS
- Improved Immune System Maturation
- Improved Immune Tolerance
- Improved Immunity Pathways
- Improved Immunity Status
- Improved Immunoglobulin A Production
- Improved Immunoglobulin Levels
- Improved Immunoinflammatory Markers
- Improved Immunologic Barrier Function
- Improved Immunological Status of Mucosa
- Improved Immunomodulation
- Improved Immunostimulatory Activity
- Improved Indigestion Symptoms
- Improved Inflammation Homeostasis
- Improved Inflammation Levels
- Improved Inflammatory Marker Profile
- Improved Inflammatory Regulation
- Improved Inflammatory Response
- Improved Inflammatory Status
- Improved Interleukin-10 Levels
- Improved Intestinal Alkaline Phosphatase Activity
- Improved Intestinal Barrier
- Improved Intestinal Barrier Function
- Improved Intestinal Barrier Integrity
- Improved Intestinal Cell Adhesion
- Improved Intestinal Cell Integrity
- Improved Intestinal Cell Proliferation
- Improved Intestinal Cell Viability
- Improved Intestinal Crypt Survival
- Improved Intestinal Cytokine Function
- Improved Intestinal Defense
- Improved Intestinal Defense Mechanism
- Improved Intestinal Development
- Improved Intestinal Digestive Enzyme Activity
- Improved Intestinal Environment
- Improved Intestinal Epithelial Barrier
- Improved Intestinal Epithelial Barrier Function
- Improved Intestinal Epithelial Cell Function
- Improved Intestinal Epithelial Intercellular Integrity
- Improved Intestinal Epithelial Permeability
- Improved Intestinal Epithelium Recovery
- Improved Intestinal Flora
- Improved Intestinal Flora Balance
- Improved Intestinal Flora Diversity
- Improved Intestinal Health
- Improved Intestinal Health from Zinc Deficiency Prevention
- Improved Intestinal Histomorphology
- Improved Intestinal Histopathology
- Improved Intestinal Immune Barrier
- Improved Intestinal Immune Response
- Improved Intestinal Immune Responsiveness
- Improved Intestinal Immunity
- Improved Intestinal Immunomodulatory Function
- Improved Intestinal Injury
- Improved Intestinal Innate Immunity
- Improved Intestinal LAB Viability
- Improved Intestinal Metabolism
- Improved Intestinal Microbial Composition
- Improved Intestinal Microbiota
- Improved Intestinal Microbiota Balance
- Improved Intestinal Microbiota Health
- Improved Intestinal Microenvironment
- Improved Intestinal Microenvironment in Ulcerative Colitis
- Improved Intestinal Microflora
- Improved Intestinal Microflora Balance
- Improved Intestinal Microflora Diversity
- Improved Intestinal Morphology
- Improved Intestinal Morphometry
- Improved Intestinal Mucosa Architecture
- Improved Intestinal Mucosal Health
- Improved Intestinal Mucosal Immunity
- Improved Intestinal Mucosal Repair
- Improved Intestinal Resistance to Salmonella Typhimurium
- Improved Intestinal Structure
- Improved Intestinal Survival
- Improved Intestinal Villi Epithelium Integrity
- Improved Intestinal Villus Height
- Improved Intestinal Villus Morphology
- Improved Iron Absorption
- Improved Iron Deficiency Anemia Treatment Efficacy
- Improved Iron Status
- Improved Irritable Bowel Syndrome Symptom Severity
- Improved Irritable Bowel Syndrome Symptoms
- Improved Irritable Bowel Syndrome Symptoms in Adults
- Improved Jejunal Health
- Improved Jejunal Morphology
- Improved Jejunal Permeability
- Improved Macroscopic Colonic Damage
- Improved Management of Colitis
- Improved Microbial Community Composition
- Improved Microbial Diversity
- Improved Microbial Metabolism Regulation
- Improved Microbial Structures
- Improved Microbiota Activity
- Improved Microbiota Diversity
- Improved Microbiota Profile
- Improved Microflora Composition
- Improved Micronutrient Availability
- Improved Mineral Absorption
- Improved Mucosal Barrier Function
- Improved Mucosal Healing
- Improved Mucosal Visibility
- Improved Neutrophil Function
- Improved Niche Colonization
- Improved Nutrient Absorption
- Improved Nutrient Absorption and Metabolism
- Improved Nutrient Digestibility
- Improved Overall Gastrointestinal Symptoms
- Improved Overall IBS Symptoms
- Improved Overall Symptom Score
- Improved Palatability and Textural Quality
- Improved Prebiotic Index
- Improved Probiotic Efficiency
- Improved Probiotic Function
- Improved Probiotic Functionality
- Improved Probiotic Functionality for Functional Foods Development
- Improved Probiotic Product Stability
- Improved Probiotic Properties
- Improved Probiotic Safety
- Improved Probiotic Suitability
- Improved Proliferative Capacity of Intestinal Cells
- Improved Protein Digestion
- Improved Quality of Life in Individuals with Crohn's Disease
- Improved Quality of Probiotic Food Products
- Improved Recovery From Colitis
- Improved Recovery of Intestinal Flora
- Improved Resistance to Foodborne Pathogens
- Improved Response to Prebiotics
- Improved Safety and Tolerability of Probiotic Consumption
- Improved Salmonella Clearance
- Improved Short-Chain Fatty Acid Production
- Improved Short-Chain Fatty Acids Levels
- Improved Spontaneous Bowel Movements
- Improved Stability of Gut Microbiota
- Improved Starch Degradation Potential
- Improved Starch Digestibility
- Improved Stool Characteristics
- Improved Stool Formation
- Improved Stool Quality
- Improved Stool Symptoms
- Improved Strain-Level Competitive Fitness
- Improved Survival Rate After E. coli Challenge
- Improved Survival Through GI Passage
- Improved Survival Under Gastrointestinal Challenges
- Improved Survival of Probiotic Bacteria
- Improved Systemic Immune Response
- Improved T Lymphocyte Subset Balance
- Improved T-Cell Cytokine Production
- Improved Tight Junction Protein Localization
- Improved Tolerance to High Doses of Probiotics
- Improved Tolerance to Intestinal Conditions
- Improved Tolerance to Saccharomyces cerevisiae
- Improved Treg/Th-17 Balance
- Improved Vaccine Efficacy
- Improved Vaccine Seroconversion
- Improved Viability of Lactic Acid Bacteria
- Improved Villus Height in Duodenum
- Improved Vitamin A Content
- Improved Water Absorption
- Improved Zinc Absorption
- Increase in Beneficial Bifidobacterial Species
- Increase in Bifidobacterium lactis HN019
- Increased Abundance of Beneficial Gut Genera
- Increased Abundance of Beneficial Microbes
- Increased Abundance of Beneficial Microorganisms
- Increased Abundance of Beneficial SCFAs-Producing Bacteria
- Increased Abundance of Bifidobacterium
- Increased Abundance of Muribaculaceae
- Increased Abundance of Peptostreptococcaceae
- Increased Abundance of Specific Bacterial Species
- Increased Acetic Acid Production
- Increased Acetic Acid in Stool
- Increased Activation of Intestinal Stem Cells
- Increased Adhesion to Enterocytes
- Increased Adhesion to Epithelia
- Increased Alpha Diversity of Jejunal Mucosa-Associated Microbiota
- Increased Anti-Inflammatory Bacteria Abundance
- Increased Anti-Inflammatory Cytokine IL-10
- Increased Anti-Inflammatory Cytokines in the Small Intestine
- Increased Anti-Inflammatory Immune Cell Populations
- Increased Anti-Inflammatory Levels
- Increased Anti-inflammatory to Pro-inflammatory Cytokine Ratio
- Increased Antigen-Specific IgG1 Levels
- Increased Apoptosis of OVA-specific TCR Tg T Cells
- Increased Autophagy in Intestinal Epithelial Cells
- Increased B. lactis HN019 DNA Copies
- Increased Bacillus Species
- Increased Bacterial Translocation
- Increased Bacteroides Levels in the Intestine
- Increased Beneficial Bacteria Populations
- Increased Beneficial Bacterial Colonization
- Increased Beneficial Bacterial Counts
- Increased Beneficial Bacterial Species
- Increased Beneficial Bifidobacteria
- Increased Beneficial Gut Bacteria
- Increased Beneficial Gut Lactic Acid Bacteria
- Increased Beneficial Gut Microbiota
- Increased Beneficial Gut Microbiota Abundance
- Increased Beneficial Indole Derivative Production
- Increased Beneficial Intestinal Metabolites
- Increased Beneficial Intestinal Microorganisms
- Increased Bifidobacteria Count
- Increased Bifidobacteria Growth
- Increased Bifidobacteria Levels in Gut Microbiota
- Increased Bifidobacterial Populations in Feces
- Increased Bifidobacterium Dominance in Faecal Microbiota
- Increased Bifidobacterium Levels
- Increased Bifidobacterium Levels in Feces
- Increased Bifidobacterium Persistence Duration
- Increased Bifidobacterium lactis GCL2505 Intestinal Proliferation
- Increased Bifidobacterium lactis Proliferation in the Intestine
- Increased Bifidobacterium longum Relative Abundance
- Increased Bifidobacterium-Dominated Gut Microbiota
- Increased Bowel Movement Frequency
- Increased Bowel Movements
- Increased Bowel Mucosal Mass
- Increased Branched Chain Fatty Acids in Colonic Digesta
- Increased Butyrate Concentration
- Increased Butyrate Concentrations in Colonic Digesta
- Increased Butyrate Levels
- Increased Butyrate Production
- Increased Butyrate-Producing Gut Bacteria
- Increased Butyric Acid Levels
- Increased Butyric Acid Production
- Increased C-Reactive Protein Levels
- Increased CCL-20 Levels
- Increased CD103+ Dendritic Cell Count
- Increased CD163+ Macrophage Density
- Increased CD3d Expression in Colon During Weaning
- Increased CD4(-)CD8(+low) T Cell Count in Ileum
- Increased CD4-Positive T-Lymphocytes in Ileal Epithelium
- Increased CD68+ Macrophage Density
- Increased Colitis Severity
- Increased Colon Barrier Biomarkers
- Increased Colon Inflammation
- Increased Colon Lactobacilli
- Increased Colonic Butyric Acid Concentrations
- Increased Colonic Lactobacilli Levels
- Increased Colonic Mucosa Adhesion
- Increased Colonic Mucosal Glutathione S-Transferase Levels
- Increased Colonization by Beneficial Bacteria (Bifidobacterium animalis subsp. lactis BB-12)
- Increased Colonization of S. thermophilus
- Increased Commensal Lactobacilli Levels
- Increased Cytokine Production
- Increased Cytokine Production in Peripheral Blood Mononuclear Cells
- Increased Cytokine Response
- Increased Defecation Frequency
- Increased Diarrhea Incidence
- Increased Duodenal Inflammation
- Increased Epithelial-Derived IgG Levels
- Increased Erythromycin-Resistant Enterobacterales Abundance in the Ileum
- Increased Faecal Bifidobacterium Lactis Content
- Increased Faecal Carboxylic Acid Concentration
- Increased Fecal Acetate Levels
- Increased Fecal Bifidobacteria Numbers
- Increased Fecal Bifidobacterial Populations
- Increased Fecal Bifidobacterium Count
- Increased Fecal Bifidobacterium breve Levels
- Increased Fecal Butyrate Levels
- Increased Fecal Calprotectin Levels
- Increased Fecal Cell Persistence
- Increased Fecal Concentration of Propionic Acid
- Increased Fecal Excretion
- Increased Fecal Immunoglobulin A Concentrations
- Increased Fecal Immunoglobulin A Levels
- Increased Fecal Immunological Biomarkers
- Increased Fecal Lactic Acid Bacteria Concentration
- Increased Fecal Lactic Acid Bacteria Counts
- Increased Fecal Lactobacillus Paracasei Levels
- Increased Fecal Lactobacillus reuteri Concentration
- Increased Fecal Lactobacillus reuteri Levels
- Increased Fecal Moisture
- Increased Fecal Moisture Content
- Increased Fecal Output
- Increased Fecal Probiotic Bacteria
- Increased Fecal Score
- Increased Fecal Secretory IgA Levels
- Increased Fecal Water Content
- Increased Foxp3 Protein Levels
- Increased Frequency of Complete Spontaneous Bowel Movements
- Increased Frequency of Loose or Watery Stools
- Increased Functional Gene Abundance in Small Intestine
- Increased Functional Genes in Caeca
- Increased GLP-2 Release
- Increased Gastrointestinal Discomfort
- Increased Gastrointestinal Symptoms
- Increased Generation of T Regulatory Cells
- Increased Genetic Diversity of Lactic Acid Bacteria Population
- Increased Gut Beneficial Microbes
- Increased Gut Bifidobacteria
- Increased Gut Bifidobacterium Count
- Increased Gut Lactic Acid Bacteria Count
- Increased Gut Lactobacillus plantarum Population
- Increased Gut Levels of Lactobacillus and Lactococcus
- Increased Gut Microbial Growth
- Increased Gut Microbial Supplementation
- Increased IFN-γ Levels
- Increased IFN-γ to IL-4 Ratio
- Increased IL-10 Concentration
- Increased IL-10 Levels
- Increased IL-10 Production
- Increased IL-10 in Mucosal Tissue
- Increased IL-12 Production
- Increased IL-12 Production in Splenocytes
- Increased IL-2 Secretion
- Increased IL-6 Levels in Early Phase
- Increased IPA Levels
- Increased IgA Production
- Increased IgA-Inducing Activity
- Increased Ileal Enterobacteriaceae Counts
- Increased Ileal Goblet Cell Count
- Increased Ileal Mucosal Colonization of Lactobacillus amylovorus
- Increased Ileum Interleukin-10 Levels
- Increased Immune Activation without Cytotoxicity
- Increased Immune Cell Presence
- Increased Immune Marker Activation
- Increased Immune Marker Levels
- Increased Immune System Activation
- Increased Immunoglobulin A Levels
- Increased Immunoglobulin A+ Cells in Small Intestine
- Increased Immunoglobulin Levels
- Increased Immunosuppressive Cytokine Production
- Increased Incidence of Abdominal Symptoms
- Increased Inflammatory Cell Counts
- Increased Inflammatory Cytokines
- Increased Inflammatory Mediator Production
- Increased Inflammatory Response
- Increased Interest in Probiotic Supplements
- Increased Interferon-Gamma Levels
- Increased Interleukin-1 Beta Production
- Increased Interleukin-1 Receptor Antagonist Production
- Increased Interleukin-10 Levels
- Increased Interleukin-10 Production in the Gut
- Increased Interleukin-12 Production
- Increased Interleukin-12p40 Production
- Increased Interleukin-2 Production
- Increased Interleukin-6 Production in Macrophages
- Increased Interleukin-8 Expression in the Ileum
- Increased Intestinal Anti-E. coli IgA Levels
- Increased Intestinal Barrier Cytoprotection
- Increased Intestinal Bifidobacteria Levels
- Increased Intestinal Bifidobacteria Population
- Increased Intestinal Bifidobacterium Levels
- Increased Intestinal Cell Adherence
- Increased Intestinal Crypt Survival
- Increased Intestinal Epithelial Cell Adhesion
- Increased Intestinal IFN-beta Levels
- Increased Intestinal IgA Levels
- Increased Intestinal IgA Secretion
- Increased Intestinal Immunoglobulin A Levels
- Increased Intestinal Inflammatory Response
- Increased Intestinal Lactic Acid Bacteria Count
- Increased Intestinal Lactobacillus sakei Levels
- Increased Intestinal Mucosal Anti-Salmonella Typhimurium Antibody Titers
- Increased Intestinal Mucosal Immune Response
- Increased Intestinal Neutrophil Levels
- Increased Intestinal Permeability Under Exercise-induced Stress
- Increased Intestinal Polyamine Levels
- Increased Intestinal Stem Cell Proliferation
- Increased Intestinal Subepidermal CD4+ Cell Levels
- Increased Intestinal T-Cell Count
- Increased Intestinal Transit Rate
- Increased Intraepithelial CD8+ Lymphocytes
- Increased Intraepithelial Leukocyte Levels
- Increased Jejunal Permeability
- Increased Lacticaseibacillus Abundance
- Increased Lactobacilli Colonization in the Gut
- Increased Lactobacillus acidophilus in Crop at 14 Days
- Increased Lactobacillus rhamnosus Presence in Stool
- Increased Late-Onset Sepsis Incidence
- Increased Levels of Actinobacteria
- Increased Levels of Autochthonous Intestinal Bacteria
- Increased Levels of Bifidobacteria
- Increased Levels of Lactobacillus Paracasei/Casei
- Increased Lymphocyte Proliferation
- Increased Lymphoid Cell Proliferation in Germ-Free Animals
- Increased Magnesium Absorption
- Increased Mast Cells in Mucosal Tissues
- Increased Metabolic Activity in the Colon
- Increased Microbial Diversity
- Increased Microbial Richness in the Large Intestine
- Increased Microbial Viability in Human Gut
- Increased Microbiota Engraftment
- Increased Mucosal Anti-Inflammatory Mediator MIF Production
- Increased Nitric Oxide Secretion
- Increased Nrf2 Level
- Increased Oxalate-Degrading Activity
- Increased Persistence of Bifidobacteria
- Increased Persistence of Probiotics in Fecal Matter
- Increased Polyphenol Level
- Increased Population of Beneficial Gut Bacteria
- Increased Population of Clostridium Histolyticum
- Increased Preference for SCFP-Containing Diet
- Increased Prevalence of Normally Formed Stools
- Increased Pro-inflammatory Cytokine Production
- Increased Pro-inflammatory Cytokine Release
- Increased Pro-inflammatory Cytokine TNFα Levels
- Increased Probiotic Activity
- Increased Probiotic B. lactis Levels
- Increased Probiotic Bacteria Abundance
- Increased Probiotic Bacteria Colonization
- Increased Probiotic Bacterial Count
- Increased Probiotic Bacterial Survival Through Upper Gastrointestinal Transit
- Increased Probiotic Co-existence
- Increased Probiotic Consumption
- Increased Probiotic Genus Proportion
- Increased Probiotic Levels
- Increased Probiotic Potential
- Increased Probiotic Tolerance
- Increased Production of Anti-inflammatory Cytokine IL-10
- Increased Production of Bioactive Metabolites
- Increased Proliferation of Administered Bifidobacteria
- Increased Proportion of Aerobic and Anaerobic Bacteria
- Increased Proportion of Intestinal Goblet Cells
- Increased Proportion of Intestinal Regulatory T Cells
- Increased Proportion of T Lymphocytes
- Increased Proportion of Verrucomicrobia in Gastrointestinal Microbiome
- Increased Protective Fecal Bifidobacteria
- Increased Protective Fecal Bifidobacterial Diversity
- Increased Protein Digestibility
- Increased Protozoa Counts
- Increased Regulatory T Cell Count
- Increased Regulatory T Cell Expansion
- Increased Regulatory T Cell Frequency
- Increased Regulatory T Cell Induction
- Increased Regulatory T Cell Populations
- Increased Regulatory T Cells in Intestinal Mucosa
- Increased Regulatory T-Cells in Mesenteric Lymphoid Nodes
- Increased Relative Abundance of Beneficial Bacteria
- Increased Resistance to Simulated Gastrointestinal Conditions
- Increased Resistant Starch
- Increased Rikenellaceae Abundance
- Increased SCFA Butyrate Levels
- Increased SCFA Production
- Increased SCFA-Producing Bacteria
- Increased Salmonella Shedding
- Increased Secretory IgA Level
- Increased Serum Anti-inflammatory Metabolites
- Increased Serum Ferritin Level
- Increased Serum Immunoglobulin A (IgA) Levels
- Increased Serum Immunoglobulin Levels
- Increased Serum Immunoglobulins
- Increased Serum Metabolites to Combat Inflammation
- Increased Serum Tumor Necrosis Factor-α Levels
- Increased Short Chain Fatty Acids
- Increased Short Chain Fatty Acids (SCFAs) Levels
- Increased Short-Chain Fatty Acid Levels
- Increased Short-Chain Fatty Acid Production
- Increased Short-Chain Fatty Acid-Producing Bacteria
- Increased Short-Chain Fatty Acids (SCFAs) Contents
- Increased Stool Consistency
- Increased Stool Frequency
- Increased Stool IgA Levels
- Increased Stool Immunoglobulin A (IgA)
- Increased Stool Looseness
- Increased Stool Moisture Content
- Increased Stool Volume
- Increased Sulfate Metabolite Level
- Increased Susceptibility to Salmonella Infection
- Increased TNF-alpha Levels in Macrophages
- Increased TNF-α Production
- Increased Th17 Polarization
- Increased Tight Junction Protein Levels
- Increased Tight Junction Proteins (Claudin-1)
- Increased Tolerance to Inflammatory Stimuli
- Increased Tolerogenic Dendritic Cells in the Intestine
- Increased Total Fecal Carboxylic Acids
- Increased Total Fecal SCFAs
- Increased Total Immunoglobulin A (IgA) Levels
- Increased Total Thiol Level
- Increased Treg Population in the Small Intestine
- Increased Tumor Necrosis Factor-Alpha Levels
- Increased Tumor Necrosis Factor-Alpha Production by Dendritic Cells
- Increased Urinary Abundance of Nutrient-Related Metabolites
- Increased Valeric Acid Levels
- Increased Vasoactive Intestinal Peptide Levels
- Increased Viable Bifidobacteria Counts
- Increased Weight Loss
- Increased ZO-1 Production in Ileal Tissues
- Induced Circadian Rhythm-Dependent Short-Chain Fatty Acid Production by Gut Microbiota
- Induced Immunomodulatory Effects
- Induced Th1 Cytokines
- Induction of Th1 Immune Response
- Inflammatory Disease Protection
- Influenced Systemic Immune Response
- Inhibited Changes in Short-Chain Fatty Acids
- Inhibited IκBα Degradation
- Inhibited α-Amylase Activity
- Lack of Long-Term Colonization of Bifidobacteria Strains
- Lack of Protection of Intestinal Morphology Against DON
- Lack of Sustainable Colonization
- Long-Lasting Immunomodulatory Effects After Weaning
- Maintained Bacterial Diversity
- Maintained Barrier Function
- Maintained Colonic Epithelial Barrier Integrity
- Maintained Colorectal Homeostasis
- Maintained Digestive Function
- Maintained Fecal Short Chain Fatty Acid Levels
- Maintained Gastrointestinal Health
- Maintained Gastrointestinal Microbiome Stability
- Maintained Gut Health
- Maintained Gut Homeostasis
- Maintained Gut Microbiome Composition
- Maintained Gut Microbiome Homeostasis
- Maintained Gut Microbiota Diversity
- Maintained Gut Microbiota Stability
- Maintained Gut Permeability
- Maintained Healthy Gut Environment
- Maintained Immune Homeostasis
- Maintained Intestinal Barrier Function
- Maintained Intestinal Barrier Integrity
- Maintained Intestinal Epithelial Homeostasis
- Maintained Intestinal Immune Tolerance
- Maintained Intestinal Microbial Abundance
- Maintained Intestinal Microbiota Balance
- Maintained Intestinal Microbiota Stability
- Maintained Intestinal Villi Integrity
- Maintained Microbiota Equilibrium
- Maintained Mucosa-Associated Immunity
- Maintained Mucosal Barrier Integrity
- Maintained Mucus Barrier Integrity
- Maintained Normal Mucosal Barrier Function
- Maintained Nutritional Quality
- Maintained Prevotella-Dominant Gut Microbiota
- Maintained Short-Chain Fatty Acid Levels During Antibiotic Treatment
- Maintained Small Intestinal Permeability
- Maintenance of Normal Intestinal Function
- Maintenance of Stable Gut Microbiota Profile
- Maintenance of Therapeutic Probiotic Levels
- Managed Gut Microbiota Disturbance
- Mature Gut Microbiota
- Matured Antigen-Presenting Cells
- Microbial Community Characterization
- Microbial Group Modulation with Bifidobacterial Reduction
- Microbiome Biomarker of Treatment Response
- Microbiome Remodeling
- Mitigated Microbiota Changes
- Moderate Changes in Gastrointestinal Bacterial Groups
- Moderate Impact on Main GI Bacterial Groups
- Modified Dominant Intestinal Bacterial Taxa
- Modified Fecal Microbiota
- Modulated Bacterial Phenotypes
- Modulated Bile Acid Profile in Ileum
- Modulated Colonic Microbiota
- Modulated Cytokine Levels
- Modulated Cytokine Production
- Modulated Dendritic Cell Function
- Modulated Diurnal Short-Chain Fatty Acid Production
- Modulated Endocannabinoid System
- Modulated Gastrointestinal Microbiota
- Modulated Gut Microbial Diversity
- Modulated Gut Microbiome Composition
- Modulated Gut Microbiota
- Modulated Host Immune Response
- Modulated Host Response
- Modulated Humoral Inflammation
- Modulated IL-18-Related Immune Response
- Modulated Immune Cell Activity
- Modulated Immune Function in Offspring
- Modulated Immune Markers
- Modulated Immune Response
- Modulated Immune System
- Modulated Immunoinflammatory Parameters
- Modulated Immunologic Response
- Modulated Immunological Profile
- Modulated Inflammation and Coagulation Interaction
- Modulated Inflammatory Cytokine Levels
- Modulated Inflammatory Response
- Modulated Intestinal Metabolite Profile
- Modulated Intestinal Microbial Community
- Modulated Intestinal Microbial Taxa
- Modulated Intestinal Microflora Composition
- Modulated Lymphocyte Populations
- Modulated Systemic Immune Response
- Modulated T Cell Response
- Modulation of Colon Epithelium by Lactate
- Modulation of Microbiota Activity
- Neutral Probiotic Delivery Through Digestion
- No Change in Abnormal Intestinal Permeability
- No Change in Colitis-Induced Inflammation
- No Change in Diarrhea
- No Change in Endogenous Bifidobacteria Species
- No Change in Faecal Butyrate Concentration
- No Change in Fecal Short-Chain Fatty Acid Concentration
- No Change in Inflammatory Cytokines
- No Change in Nutrient Digestibility or Blood/Immune Markers
- No Demonstrated Efficacy for Isolated Bifidobacterium Use
- No Difference in Adverse Events
- No Illness or Death Despite Bacterial Translocation
- No Improvement in Gastrointestinal Permeability
- No Increase in Fecal Incontinence
- No Meaningful Change in IL-10
- No Meaningful Change in IL-8
- No Protection Against Salmonella-Induced Inflammation
- No Significant Change in Duration of Gastrointestinal Symptoms
- No Significant Effect on Toxin-Producing C. difficile Carriage
- No Worsening of Gastrointestinal Symptoms
- Non-Toxicity to Normal Colon Cells
- Normalized Gut Metabolites
- Normalized Gut Microbiota
- Normalized Intestinal Microbiota
- Normalized Osmotic Pressure in the Large Intestine
- Normalized Stool Consistency
- Normalized Stool Type
- Partial Restoration of Intestinal Cell Proliferation
- Partial Restoration of Intestinal Microbiota
- Potential Probiotic Benefits
- Potential Probiotic Health Effects
- Presence of Lactobacillus gasseri BNR17 in Feces
- Presence of Lactobacillus salivarius CECT5713 in Feces
- Presence of Lactococcus Lactis in Gut Microbiota
- Presence of Viable L. acidophilus La-5 Strains in Feces
- Preserved Colon Goblet Cell Density
- Preserved Endogenous Bifidobacteria Composition
- Preserved Gastrointestinal Histological Structure
- Preserved Gut Microbiota Diversity
- Preserved Small Intestinal Villus Integrity
- Prevention and Treatment of Inflammatory Diseases
- Prevention of Aberrant Inflammatory Response
- Prevention of Autoimmune Disorders
- Prevention of Colitis
- Prevention of Colorectal Cancer
- Prevention of Inflammatory Bowel Disease Characteristics
- Prevention of Intestinal Barrier Damage
- Prevention of Intestinal Dysbiosis
- Probiotic Adherence Variability Based on Host Factors
- Probiotic-Related Infection
- Production of Probiotic Peptides
- Promoted Recovery from Colitis-Associated Dysbiosis
- Promotion of Healthy Gut Microbial Colonization
- Protected Enterocyte Structure
- Protected Epithelial Cells Under Inflammatory Conditions
- Protected Intestinal Health
- Protected Small Intestinal Integrity
- Protection Against Brush Border Damage Induced by Bacteria
- Protection Against Colitis
- Protection Against Gut Tissue Damage
- Protection Against Induced Colitis
- Protection Against Induced Colon Cancer
- Protection Against Intestinal Epithelial Injury
- Protection of Colonic Mucosa from C. difficile Toxins
- Rapid Galactooligosaccharide Degradation During Gastrointestinal Transit
- Rebalanced Th1/Th2/Th17 Cell Ratios
- Recovered Microbiome-associated Dysbiosis
- Recovery of BB-12 from Feces
- Reduced AQP8 Expression in Colon
- Reduced Abdominal Pain Severity
- Reduced Abdominal Symptoms
- Reduced Aberrant Crypt Number
- Reduced Abundance of Enterobacteriaceae Species
- Reduced Abundance of Odoribacter
- Reduced Abundance of Pathobionts
- Reduced Abundance of Pro-Pathogenic Bacteria
- Reduced Abundance of Pro-inflammatory Bacteria
- Reduced Abundance of Proteobacteria
- Reduced Abundance of Streptococcus Bacteroides Enterococcus Veillonella
- Reduced Acetate Production
- Reduced Acetate to Propionate Ratio
- Reduced Adherence of Campylobacter jejuni to Intestinal Cells
- Reduced Anti-Enterococcus faecalis IgG Levels
- Reduced Antinutrient Levels
- Reduced Apoptotic Shedding of Epithelial Cells
- Reduced Bacterial Translocation
- Reduced Bacterial Translocation in Mesenteric Adipose Tissue
- Reduced Bacterial Translocation to Mesenteric Lymph Nodes
- Reduced Bacteroides Abundance
- Reduced Bacteroides Fragilis Group Numbers
- Reduced Beta-Glucuronidase Activity
- Reduced Bifidobacterial Population
- Reduced Bifidobacterium Counts
- Reduced Bifidobacterium longum
- Reduced Bitter-Related Organic Acids
- Reduced Bloating
- Reduced Bloating Severity
- Reduced Body Weight in TNBS Colitis
- Reduced Bowel Discomfort Symptoms
- Reduced Bowel Dysfunction
- Reduced Bowel Movement Frequency
- Reduced Bowel Movements
- Reduced Brachyspira hyodysenteriae Growth
- Reduced Butyrate Production
- Reduced C-Reactive Protein Level
- Reduced C-Reactive Protein Levels
- Reduced CD4+ T Cell Lymphocytes in Intestinal Mucosa
- Reduced Campylobacter Coli Colonization
- Reduced Campylobacter jejuni Inhibition
- Reduced Campylobacter jejuni Survival
- Reduced Circulating Endotoxin
- Reduced Clinical Symptoms of Colitis
- Reduced Clostridia Counts
- Reduced Clostridium Cluster IV Content
- Reduced Clostridium Counts
- Reduced Clostridium Perfringens Numbers
- Reduced Clostridium Species Numbers
- Reduced Coliform Levels in the Jejunum
- Reduced Colitis Development
- Reduced Colitis Inflammation
- Reduced Colitis Recurrence
- Reduced Colitis Risk
- Reduced Colitis Severity
- Reduced Colitis Symptoms
- Reduced Colitis-Associated Weight Loss
- Reduced Colitis-Related Mortality
- Reduced Colon Cancer Risk
- Reduced Colon Pain
- Reduced Colon Shortening
- Reduced Colonic Enterobacteriaceae Species
- Reduced Colonic Inflammation
- Reduced Colonic Microscopic Damage
- Reduced Colonic Mucosa Damage
- Reduced Colonic Myeloperoxidase Levels
- Reduced Colonic Oxidative Damage
- Reduced Colonic Pathology
- Reduced Colonic Permeability
- Reduced Colonisation of Lactobacillus casei Strain Shirota
- Reduced Colonization of Cronobacter sakazakii in Enterocytes
- Reduced Colonization with Multiple Organisms
- Reduced Colorectal Cancer Risk Associated with Ulcerative Colitis
- Reduced Colorectal Tumorigenesis
- Reduced Constipation
- Reduced Constipation Incidence
- Reduced Corticosteroid Usage
- Reduced Crohn's Disease Symptoms
- Reduced Crypt Cell Proliferation
- Reduced Cyclooxygenase-2 Levels
- Reduced Cytokine Production in Colonic Epithelial Cells
- Reduced Days with Defecation Urgency
- Reduced Days with Diarrhea
- Reduced Defense Gene Activity for Gram-Negative Pathogens
- Reduced Deferribacteres in Gut Microbiota
- Reduced Detection Rates of Clostridium
- Reduced Diarrhea
- Reduced Diarrhea Episodes
- Reduced Diarrhea Frequency
- Reduced Diarrhea Rate
- Reduced Diarrhea Severity
- Reduced Diarrhea Symptoms
- Reduced Digestive Symptoms
- Reduced Disease Activity Index Scores
- Reduced Disease Activity Index in Colitis Model
- Reduced Disease Activity in Colitis
- Reduced Disease Activity in Ulcerative Colitis
- Reduced Dysbiosis
- Reduced Dysbiosis-Associated Bacteria Growth
- Reduced E. coli Activity
- Reduced EHEC Colonization
- Reduced Elevated Immune Cells in Mesenteric Lymph Nodes
- Reduced Endotoxin Levels
- Reduced Enteritis
- Reduced Enteritis Index
- Reduced Enterobacteria Levels
- Reduced Enterobacteriaceae Counts
- Reduced Enterobacteriaceae Levels in Feces
- Reduced Enterobacteriaceae in Intestines
- Reduced Enterobacterial Counts
- Reduced Enterocyte Damage
- Reduced Enterocyte Injury from Capsaicin
- Reduced Enterocyte Layer Colonization by Salmonella enterica
- Reduced Enteropathogen Adhesion
- Reduced Enteropathogenic Bacteria
- Reduced Enteropathy
- Reduced Enterotoxigenic Bacteroides fragilis (ETBF) Levels
- Reduced Epithelial Barrier Disruption
- Reduced Epithelial Permeability
- Reduced Escherichia Abundance
- Reduced Escherichia Coli Levels
- Reduced Escherichia Vulneris Abundance
- Reduced Escherichia coli Population
- Reduced Expression of ADAM17
- Reduced Expression of Caspase-1 in Ileum
- Reduced Expression of Inflammation-Related Genes
- Reduced Expression of Proinflammatory Mediators
- Reduced FITC-Dextran Flux Upregulation
- Reduced Faecal Calprotectin
- Reduced Faecal Clostridium Population
- Reduced Faecal Levels of Total Lactobacillus Species
- Reduced Faecal pH
- Reduced Fecal Bacterial Enzyme Activity
- Reduced Fecal Bacterial Nitroreductase Activity
- Reduced Fecal Calprotectin Immunoglobulin A
- Reduced Fecal Calprotectin Levels
- Reduced Fecal Clostridium Levels
- Reduced Fecal Coliform Count
- Reduced Fecal Coliform Levels
- Reduced Fecal Enterobacilli
- Reduced Fecal Enterococci
- Reduced Fecal Escherichia coli Levels
- Reduced Fecal Excretion of Bacteroides Fragilis
- Reduced Fecal Hydrogen Sulfide Emissions
- Reduced Fecal Immune Biomarkers
- Reduced Fecal Loading
- Reduced Fecal Metabolite Levels
- Reduced Fecal Microbiota Diversity
- Reduced Fecal Score
- Reduced Fecal Secondary Bile Acid Contents
- Reduced Fecal Staphylococcus aureus Populations
- Reduced Fecal p-Cresol Levels
- Reduced Fermentation Time
- Reduced Ferritin Level
- Reduced Flatulence
- Reduced Flavonifractor Abundance
- Reduced Flavonoid Levels
- Reduced Fluctuations in Intestinal Bacteria
- Reduced Fluid Secretion in the Ileum
- Reduced Functional Iron Deficiency
- Reduced Fungal Enteric Colonization
- Reduced Fusobacterium Abundance
- Reduced Gastrointestinal Cancer Risk
- Reduced Gastrointestinal Discomfort Symptoms
- Reduced Gastrointestinal Disease Incidence in Children
- Reduced Gastrointestinal Disease Symptoms
- Reduced Gastrointestinal Disorder Symptoms
- Reduced Gastrointestinal Disorders
- Reduced Gastrointestinal Inflammation
- Reduced Gastrointestinal Leakage
- Reduced Gastrointestinal Symptom Rating Scale Score
- Reduced Gastrointestinal Symptoms
- Reduced Gastrointestinal Symptoms Score
- Reduced Gastrointestinal Tract Histological Damage
- Reduced Glucose Absorption
- Reduced Groalpha Secretion
- Reduced Gut Barrier Defect
- Reduced Gut Damage
- Reduced Gut Disorders
- Reduced Gut Humoral Proinflammatory Response
- Reduced Gut IFN-γ Production
- Reduced Gut Inflammation
- Reduced Gut Leakage
- Reduced Gut Membrane Barrier Damage
- Reduced Gut Permeability
- Reduced Gut Proteobacteria
- Reduced Harmful Bacteria Fecal Excretion
- Reduced Harmful Bacteria in Intestinal Microbiota
- Reduced Harmful Gut Bacteria
- Reduced Harmful Intestinal Bacteria
- Reduced Harmful Intestinal Metabolites
- Reduced Histologic Remission
- Reduced Histological Damage Scores
- Reduced Histopathological Damage
- Reduced IBD Symptoms
- Reduced IBS Severity
- Reduced IL-10 Expression in Ileum
- Reduced IL-17 Production in Splenocytes
- Reduced IL-18 Expression in Ileum
- Reduced IL-1β Expression in Ileum
- Reduced IL-1β Levels
- Reduced IL-6 Production
- Reduced IL-6 Secretion
- Reduced IL6 Production in Intestinal Epithelial Cells
- Reduced Ileal Oxidative Damage
- Reduced Ileum Inflammation
- Reduced Ileum Mucosa Damage
- Reduced Immune Cell Infiltration
- Reduced Immunogenicity After Oral Vaccination
- Reduced Immunoinflammatory Markers
- Reduced Impact on Existing Indigenous Microbiota
- Reduced Incidence of Acute Colitis
- Reduced Incidence of Chronic Diarrhea
- Reduced Incidence of Chronic Inflammatory Diseases in Smokers
- Reduced Incidence of Colon Cancer
- Reduced Incidence of Gastrointestinal Adverse Events
- Reduced Incidence of Inflammatory Bowel Diseases
- Reduced Incidence of Lactobacillus Bacteremia
- Reduced Incidence of Ulcers
- Reduced Incidence of Watery Diarrhea
- Reduced Inducible Nitric Oxide Synthase Expression in Intestinal Tissue
- Reduced Inflammation
- Reduced Inflammation Levels
- Reduced Inflammation Markers
- Reduced Inflammation from Salmonella Typhimurium
- Reduced Inflammation in Dendritic Cells
- Reduced Inflammation in Inflammatory Bowel Disease
- Reduced Inflammation in Intestinal Enterocytes
- Reduced Inflammation in Premature Intestinal Cells
- Reduced Inflammation via Gut Microbiota
- Reduced Inflammatory Biomarker Level
- Reduced Inflammatory Cell Activity
- Reduced Inflammatory Cytokine Secretion from Activated T Cells
- Reduced Inflammatory Cytokines (TNF-α, IFN-γ, IL-6)
- Reduced Inflammatory Diseases
- Reduced Inflammatory Effects
- Reduced Inflammatory Factor Production
- Reduced Inflammatory Immune Mediators
- Reduced Inflammatory Infiltrate
- Reduced Inflammatory Injury
- Reduced Inflammatory Marker IL-1β
- Reduced Inflammatory Markers in Crohn's Disease
- Reduced Inflammatory Markers in Ulcerative Colitis
- Reduced Inflammatory Mediators
- Reduced Inflammatory Molecules
- Reduced Inflammatory Parameters
- Reduced Inflammatory Pathway Activity
- Reduced Inflammatory Pathways
- Reduced Inflammatory Processes
- Reduced Inflammatory Protein Activation
- Reduced Inflammatory Response
- Reduced Inflammatory Response in Intestinal Cells
- Reduced Inflammatory Response to Inflammatory Stimulus
- Reduced Inflammatory Status
- Reduced Inflammatory Tone
- Reduced Injury-Induced Gut Inflammation
- Reduced Innate Immune Cell Activation
- Reduced Interferon-Gamma Levels
- Reduced Interleukin-10 Levels
- Reduced Interleukin-22 Level
- Reduced Interleukin-6 Production
- Reduced Interleukin-8 Secretion
- Reduced Intestinal Aging
- Reduced Intestinal Cell Adhesion
- Reduced Intestinal Cell Death
- Reduced Intestinal Damage
- Reduced Intestinal Epithelial Apoptosis
- Reduced Intestinal Fibrosis
- Reduced Intestinal Histological Damage
- Reduced Intestinal Hyperpermeability
- Reduced Intestinal Immunopathology
- Reduced Intestinal Inflammation
- Reduced Intestinal Inflammation Severity
- Reduced Intestinal Lesion Scores
- Reduced Intestinal Mucosal Immune Response
- Reduced Intestinal Myeloperoxidase Level
- Reduced Intestinal NE Lesion Score
- Reduced Intestinal Oxidative Damage
- Reduced Intestinal Pathogen Prevotella
- Reduced Intestinal Pathogenic Bacteria
- Reduced Intestinal Pathology
- Reduced Intestinal Pathology Changes
- Reduced Intestinal Permeability
- Reduced Intestinal Permeability Defect
- Reduced Intestinal Proinflammatory Cytokine Levels
- Reduced Intestinal Salmonella Burden
- Reduced Intestinal Tissue Damage
- Reduced Intestinal Tissue Injury
- Reduced Irritable Bowel Syndrome Symptoms
- Reduced LPS Translocation
- Reduced LPS-Induced Cellular Activity
- Reduced Levels of Anti-Inflammatory Cytokines
- Reduced Levels of Pro-Inflammatory Cytokines (IL-1β, IL-6, IFN-γ, TNF-α)
- Reduced Lipid Peroxidation in Colonic Mucosa
- Reduced Listeria Colonization
- Reduced Listeria Monocytogenes Survival
- Reduced Local Inflammation
- Reduced Low-grade Intestinal Inflammation
- Reduced Lower Intestinal pH
- Reduced MPO Levels
- Reduced Malondialdehyde Generation
- Reduced Metabolic Functions of Intestinal Microbiota
- Reduced Methane Metabolism
- Reduced Methanobrevibacter Levels
- Reduced Microbial Richness
- Reduced Microbial Translocation
- Reduced Mucin Gene Transcription
- Reduced Mucosal Adherent Citrobacter rodentium
- Reduced Mucosal Damage
- Reduced Mucosal Inflammation
- Reduced Mucosal Permeability
- Reduced Mucosal Pro-Inflammatory Activity
- Reduced Mucosal Thickness
- Reduced Mycotoxin Bioavailability
- Reduced N-acetyl-β-glucosaminidase Activity
- Reduced NDF Digestibility
- Reduced NF-kappaB Activation due to S. Typhimurium
- Reduced NF-kappaB-DNA Binding
- Reduced NSAID Consumption
- Reduced Neurally Evoked Ion Secretion in the Colon
- Reduced Neutrophil Extracellular Trap Formation
- Reduced Neutrophil Infiltration
- Reduced Nuclear Factor Kappa B Activation
- Reduced Occurrence of Soft Stools
- Reduced Odds of Probiotic Lactobacilli Successful Colonization
- Reduced Oral Aphthae Symptoms
- Reduced Oral Aphthosis Frequency
- Reduced Oxalate Nephropathy
- Reduced Oxidative Damage in Serum
- Reduced Oxidative Stress in Ileum Mucosa
- Reduced Oxidative Stress in Intestinal Epithelial Cells
- Reduced Painful Defecation
- Reduced Pathogen Translocation to Visceral Tissues
- Reduced Pathogenic Bacillus Cereus Levels
- Reduced Pathogenic Microorganism Activity
- Reduced Pathological Characteristics of the Intestinal Tract
- Reduced Pathological Symptoms
- Reduced Percentage of Bacteroidaceae in Gut Microbiota
- Reduced Percentage of Clostridium lituseburense and Clostridium histolyticum
- Reduced Peripheral Inflammation
- Reduced Phosphorus Level
- Reduced Plasma CRP Levels
- Reduced Plasma IL-10 Levels
- Reduced Plasma Lipopolysaccharide Levels
- Reduced Plasma Malondialdehyde Levels
- Reduced Plasma Vitamin K Levels
- Reduced Population of Fusobacterium prausnitzii
- Reduced Portal Vein LPS Levels
- Reduced Precursor Amino Acid Availability
- Reduced Prevalence of Iron Deficiency
- Reduced Prevalence of Proteobacteria
- Reduced Pro-Inflammatory Bacteria Levels
- Reduced Pro-Inflammatory Cytokine Synthesis
- Reduced Pro-Inflammatory Factor TNF-α
- Reduced Pro-Inflammatory Immune Activity
- Reduced Pro-Inflammatory Mediator Production
- Reduced Pro-inflammatory Biomarker Level
- Reduced Pro-inflammatory Cytokine Expression in Ileum
- Reduced Pro-inflammatory Cytokine Interleukin-8 Levels
- Reduced Pro-inflammatory Cytokine Production in LPS-stimulated Cells
- Reduced Pro-inflammatory Cytokine Release
- Reduced Pro-inflammatory Effect
- Reduced Pro-inflammatory Immune Responses
- Reduced Pro-inflammatory Mediator Levels
- Reduced Proinflammatory Cytokine Production
- Reduced Proinflammatory Cytokine Secretion
- Reduced Proinflammatory Factors
- Reduced Proinflammatory Profile
- Reduced Proinflammatory Profile from Cow Milk Formula
- Reduced Proinflammatory Signaling
- Reduced Proinflammatory/Anti-inflammatory Cytokine Ratios
- Reduced Proportion of Fusobacteria
- Reduced Proportion of Pathogenic Genera
- Reduced Proportion of Patients with Loose Stools
- Reduced Proportion of Proteobacteria
- Reduced Putrefactive Short-Chain Fatty Acids
- Reduced Radiological Damage in the Gut
- Reduced Reactive Oxygen Species Formation
- Reduced Recurrent Clostridioides difficile Infection Incidence
- Reduced Relative Abundance of Bacteroidales
- Reduced Relative Abundance of Coriobacteriaceae
- Reduced Relative Abundance of Escherichia-Shigella
- Reduced Relative Abundance of Sutterella
- Reduced Release of Inflammatory Mediators (TNF-α, IL-6, IL-1β, IL-10)
- Reduced Richness Indicators in Ileum
- Reduced Risk of Chronic Inflammatory Diseases
- Reduced Risk of Infection
- Reduced Risk of Prolonged Diarrhea
- Reduced Ruminococcus Abundance
- Reduced S. Enteritidis Invasion
- Reduced S. Typhimurium Infection
- Reduced Salmonella Activity
- Reduced Salmonella Enterica Invasion
- Reduced Salmonella Translocation
- Reduced Salmonella Typhimurium Activity
- Reduced Secretory IgA Content in Faeces
- Reduced Secretory Immunoglobulin A in Stools
- Reduced Sellimonas Abundance
- Reduced Sensitivity to Tetrodotoxin (TTx) Inhibition in Short-circuit Current Response
- Reduced Serum Anti-Lactic Acid Bacteria IgA Levels
- Reduced Serum Diamine Oxidase Activity
- Reduced Serum Endotoxin Level
- Reduced Serum Inflammatory Cytokines
- Reduced Serum LPS Levels
- Reduced Serum TNF-Alpha Level
- Reduced Serum Tumor Necrosis Factor-α
- Reduced Severe Necrotizing Enterocolitis (NEC)
- Reduced Severity of Acute Colitis
- Reduced Severity of Chemotherapy-Induced Enteropathy
- Reduced Severity of Gastrointestinal Disorders
- Reduced Short-Chain Fatty Acid Levels in Feces
- Reduced Short-Chain Fatty Acid Levels in the Colon
- Reduced Short-Chain Fatty Acids (SCFA)
- Reduced Sitosterol Absorption
- Reduced Small-Intestinal Damage
- Reduced Steroid Usage
- Reduced Stool Consistency
- Reduced Stool pH
- Reduced Stress-Induced Intestinal Hyperpermeability
- Reduced Stress-Mediated Visceral Hyperalgesia
- Reduced Stress-Related Abdominal Dysfunction
- Reduced Sulphite-Reducing Clostridia
- Reduced Susceptibility to Enteric Infection
- Reduced Susceptibility to Inflammatory Exposure
- Reduced Swede Score
- Reduced Symptoms of Oral Aphthous Ulcers
- Reduced Systemic Endotoxemia at Rest
- Reduced TLR Inflammatory Activation
- Reduced TMAO Levels
- Reduced TNF Production
- Reduced TNF-α Levels in Mesenteric Lymph Nodes
- Reduced TNF-α Secretion
- Reduced TNF-α Signaling
- Reduced Th17/Tregs Cell-Differentiation Ratio in Mesenteric Lymph Nodes
- Reduced Time Spent for Defecation
- Reduced Time to First Formed Stool
- Reduced Time to Maximum Amino Acid Concentration
- Reduced Tissue Damage from Colitis
- Reduced Total Immune Cells in Draining Lymph Nodes
- Reduced Transepithelial Resistance
- Reduced Tumor Necrosis Factor Alpha
- Reduced Tumor Necrosis Factor-alpha Level
- Reduced Tumor Necrosis Factor-α (TNF-α)
- Reduced Tumor Necrosis Factor-α Levels
- Reduced Turicibacter Abundance
- Reduced Ulcerative Colitis Symptoms
- Reduced Urgency of Bowel Movements
- Reduced Urinary Oxalate Excretion
- Reduced Valeric Acid Levels
- Reduced Villus Height
- Reduced Visceral Pain
- Reduced Watery Stools
- Reduced Weight Loss in Colitis Mice
- Reduced Yersinia Pseudotuberculosis Invasion
- Reduced Zonulin Level
- Reduced γ-Proteobacteria Levels in Human Milk-Fed Infants
- Reestablished Intestinal Microecology
- Regression of Gastrointestinal Disorders
- Regulated Colonic Bacterial Flora
- Regulated Cytokine Levels
- Regulated Gastrointestinal Function
- Regulated Gut Microbiota
- Regulated Gut Microbiota Metabolic Function
- Regulated Host Epithelial Cells
- Regulated Immune Response
- Regulated Inflammation
- Regulated Inflammatory Cytokines
- Regulated Inflammatory Markers
- Regulated Inflammatory Process
- Regulated Inflammatory Responses
- Regulated Interleukin 8 Levels
- Regulated Intestinal Barrier Function
- Regulated Intestinal Microbiota
- Regulated Intestinal Microbiota Balance
- Regulated Intestinal Microorganisms
- Regulated Microbial Metabolism
- Regulated Microbiota Function
- Regulated Systemic Immune Response Imbalance
- Regulated Tryptophan Metabolism
- Relieved Gastrointestinal Symptoms
- Relieved Intestinal Impairments
- Remodeled Intestinal Microbiota
- Repaired Colon Tissue
- Reproduced Protective Effect via Extracellular Vesicles
- Requirement for Sustained Dosage in Gastrointestinal Tract
- Restored Aggregation Phenotype and Protective Effect on Colitis
- Restored Barrier Function
- Restored Colonic Water Transport
- Restored Endogenous Microbiota Equilibrium
- Restored Goblet Cell Count
- Restored Goblet Cell Function
- Restored Gut Microbiome Balance
- Restored Gut Microbiota
- Restored Gut Microbiota Diversity
- Restored Gut Microbiota Homeostasis
- Restored Gut Microbiota Structure
- Restored Healthy Gut Microbial Balance
- Restored Intestinal Barrier Function
- Restored Intestinal Microbiota Balance
- Restored Intestinal Structure
- Restored Microbial Balance
- Restored Microbial Diversity
- Restored Microbiome Composition
- Restored Mucin-2 Levels
- Restored Mucus Layer Integrity
- Restored Normal Microbiota
- Restored Protective Effect in Colitis
- Restored Regulatory T Cell Population in Mesenteric Lymph Nodes
- Restored Short-Chain Fatty Acid Levels
- Reversed Toxin-Induced Inhibition of Protein Synthesis in Colonic Cells
- Safety Profile of Bifidobacterium Infantis
- Safety of Bifidobacterium infantis Supplementation
- Safety of Probiotic Strain Lactobacillus rhamnosus PRSF-L477
- Safety of Probiotic Supplementation
- Selective Consumption of Human Milk Oligosaccharides (HMOs)
- Significant Bacterial Translocation with Intraperitoneal Administration
- Stabilized Cytokine Levels
- Stabilized Fecal Dry Matter Percentage
- Stabilized Fecal Microbiota
- Stabilized Fecal Secondary Bile Acids
- Stabilized Gut Microbiota
- Stabilized Intestinal Microbiota
- Stable Bowel Function
- Stable Cytokine Levels in Gut-Associated Lymphoid Tissue
- Stable Fecal pH
- Stable Immune System Responses
- Stable Systemic Inflammatory Response
- Stimulation of Immune Cells
- Successful Gut Colonization
- Suppressed Inflammatory Chemokine Secretion
- Survival Through Human Intestine
- Sustained Anti-Inflammatory Gene Transcription
- Sustained Bifidobacteria Populations
- Tolerance to Lactobacillus rhamnosus PRSF-L477
- Unchanged Colonic Transit Time
- Unchanged Duration of Diarrhoea in Outpatient Children
- Unchanged Fecal Antibiotic Resistance
- Unchanged Fecal IgA Levels
- Unchanged Gastrointestinal Resistance
- Unchanged Gastrointestinal Symptoms
- Unchanged Gut Microbiota Diversity
- Unchanged IFN-γ Levels
- Unchanged Intestinal Bacterial Concentrations
- Unchanged Risk of Sepsis
- Unchanged Severe Diarrhea
- Unchanged Stool Consistency or Bowel Frequency
- Unchanged Stool Frequency
- Upregulated Macrophage Inhibitory Factor
- Viability of Probiotic Bacteria in Cheese
- Viable Probiotic Strain Recovery
- Worsened Fecal Scores